Paul, Weiss, Rifkind, Wharton & Garrison LLP
1285 Avenue of the Americas
New York, New York 10019-6064
March 23, 2021
VIA EDGAR
Ms. Sonia Bednarowski
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: | Alignment Healthcare, Inc. | |||
Amendment No. 1 to Registration Statement on Form S-1 | ||||
Filed March 18, 2021 | ||||
File No. 333-253824 |
Dear Ms. Bednarowski:
On behalf of Alignment Healthcare, Inc., a Delaware corporation (the Company), we hereby submit in electronic form the accompanying Amendment No. 2 (Amendment No. 2) to the publicly filed Registration Statement on Form S-1 of the Company (as amended, the Registration Statement), together with exhibits, marked to indicate changes from Amendment No. 1 to the Registration Statement submitted to the Securities and Exchange Commission (the Commission) on March 18, 2021.
Amendment No. 2 reflects changes made in response to the comment received in a letter from the Staff of the Commission (the Staff), dated March 22, 2021 (the Comment Letter), and certain other updates. Set forth below is the Companys response to the Staffs comment.
Amendment No. 1 to Registration Statement on Form S-1
Prospectus Summary, page 1
1. | Please include a summary here of the Stockholders Agreement with General Atlantic and Warburg Pincus, and disclose here the percentage of beneficial ownership each will hold following the completion of your offering. |
Response: The Company acknowledges the Staffs comment and has revised the Registration Statement in response to the Staffs comment. Please see page 16 of Amendment No. 2.
* * *
If you have any questions regarding Amendment No. 2 or the response contained in this letter, please do not hesitate to contact the undersigned at (212) 373-3434.
Sincerely, | ||
/s/ Christopher J. Cummings | ||
Christopher J. Cummings |
cc: | Rolf Sundwall | |
Sharon Blume | ||
Justin Dobbie | ||
Securities and Exchange Commission | ||
John Kao | ||
Thomas Freeman | ||
Michael Foster | ||
Alignment Healthcare, Inc. | ||
Khurram Siddiqui | ||
Deloitte & Touche LLP | ||
Byron B. Rooney | ||
Pedro J. Bermeo | ||
Davis Polk & Wardwell LLP | ||
Christian Kurtz | ||
Paul, Weiss, Rifkind, Wharton & Garrison LLP |